Turner Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Turner Investments’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-89,750	Closed	-$1.28M	–	213
2015 Q4	$1.28M	Hold	89,750	–	–	0.26%	113
2015 Q3	$1.05M	Sell	89,750 -65,530	-42%	-$983K	0.21%	140
2015 Q2	$2.73M	Buy	155,280 +29,460	+23%	+$459K	0.5%	68
2015 Q1	$1.88M	Buy	125,820 +46,930	+59%	+$627K	0.34%	97
2014 Q4	$916K	Buy	78,890 +19,310	+32%	+$210K	0.11%	281
2014 Q3	$694K	Buy	+59,580	New	+$621K	0.04%	382

Other funds holding AMPH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Turner Investments's AMPH Position: Q1 2016 in Review

Turner Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2016, closing a stake of 89,750 shares — an estimated $1.28M sold.

Turner Investments first reported a position in AMPH in Q3 2014 and held it in 6 quarters. The position peaked at $2.73M in Q2 2015. 95 funds tracked by Wall St. Rank hold AMPH as of Q1 2016.

Turner Investments reported no remaining Amphastar Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Turner Investments sold 89,750 Amphastar Pharmaceuticals shares in Q1 2016, an estimated $1.28M.
Turner Investments first reported a position in Amphastar Pharmaceuticals in Q3 2014 and held it in 6 quarters.
Turner Investments's Amphastar Pharmaceuticals position peaked at $2.73M in Q2 2015.
95 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2016.

Based on Turner Investments's 13F filing for Q1 2016, filed 13 May 2016.